CLINICAL NEWS

ISMP warns of sound-alike drug names mix-up

The Institute for Safe Medication Practices is warning pharmacists and other healthcare providers about reported mix-ups of Durezol, a prescription eyedrop solution, and Durasal, a prescription wart remover. » More

Blue Shield of California stops coverage of bevacizumab for breast cancer

Blue Shield of California will no longer pay for the use of bevacizumab (Avastin, Genentech) to treat metastatic breast cancer. » More

Resource Center: Oral Anticoagulation in Atrial Fibrillation

Atrial fibrillation afflicts more than 2.3 million persons in the United States and is expected to increase 2.5-fold by 2050. To find risk stratifying tools and articles on emerging oral anticoagulant therapies, click here.

Asthma tied to poorer diabetes control in kids

Children with diabetes may have a higher-than-average rate of asthma, and those with both conditions seem to have a tougher time keeping their blood sugar under control, a recent study suggests. » More

FDA ACTIONS

FDA approves clindamycin injection

FDA recently approved clindamycin injection, USP (Sagent Pharmaceuticals/Strides Arcolab), an antibiotic used to treat bacterial infections. » More

PAIN MANAGEMENT

Patient-provider communication vital for effective pain management

The American Pain Foundation recently released survey results showing that 17% of adults with chronic pain who have tried to reach their primary pain-care providers with questions face difficulties doing so. » More

DRUG SUPPLY

FDA takes part in global efforts to combat unsafe internet drugs

FDA and other regulatory and international partners recently completed the International Internet Week of Action. This year’s operation focused on websites that purvey illegal and dangerous medications. » More

Doxorubicin manufacturer anticipates continued supply shortages

Johnson & Johnson has reported that a limited supply of doxorubicin (Doxil) will become available within the next 6 weeks, but the company warned that the amount would not be sufficient for all patients currently on waiting lists. » More

E-TOOLS

Afib app helps providers explain heart care to patients

A collaboration of healthcare leaders and organizations, known as AF Stat: A Call to Action for Atrial Fibrillation, recently released the AFib Educator 2.0, a free smartphone app and desktop widget. » More

Online tools help healthcare professionals use CER

Healthcare professionals now have 2 new online tools to help them compare the effectiveness, benefits, and harmful effects of different treatment options. » More

Voices

•	Anticoagulation update
•	JP at Large
•	View from the Zoo
•	Viewpoints
•	Regulatory & Legal

Meetings & Events

Digital Edition

•	View current edition

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.